We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+6.25%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$325B
AUM Growth
+$19.8B
Cap. Flow
+$3.2B
Cap. Flow %
0.99%
Top 10 Hldgs %
12.37%
Holding
6,814
New
216
Increased
2,666
Reduced
3,277
Closed
152

Sector Composition

Rank Sector Weight
1 Financials 9.69%
2 Technology 9.44%
3 Healthcare 8.03%
4 Consumer Discretionary 7.35%
5 Communication Services 6.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVM icon
6351
CEL-SCI Corp
CVM
$21.3M
$0 ﹤0.01%
3
DARE icon
6352
Dare Bioscience
DARE
$18.6M
$0 ﹤0.01%
7
-193
-97% -$27.9K
EDSA icon
6353
Edesa Biotech
EDSA
$50.6M
0
ENLV icon
6354
Enlivex Ltd
ENLV
$32.8M
-1
Closed -$1K
EQS icon
6355
Equus Total Return
EQS
$16.2M
$0 ﹤0.01%
180
FGNX
6356
FG Nexus Inc
FGNX
$43.7M
-8
Closed -$8K
GDS icon
6357
GDS Holdings
GDS
$6.41B
-7,366
Closed -$64K
GEG icon
6358
Great Elm Group
GEG
$68.4M
$0 ﹤0.01%
3
+1
+50% +$3
GTN.A icon
6359
Gray Media Inc
GTN.A
$699M
-200
Closed -$2K
JAGX icon
6360
Jaguar Health
JAGX
$5.11M
0
LEDS icon
6361
SemiLEDS
LEDS
$16.1M
$0 ﹤0.01%
+64
New +$209
LITB
6362
LightInTheBox
LITB
$54.2M
$0 ﹤0.01%
6
-226
-97% -$3.99K
LRGF icon
6363
iShares US Equity Factor ETF
LRGF
$3.55B
-25,022
Closed -$669K
MRKR icon
6364
Marker Therapeutics
MRKR
$18.7M
$0 ﹤0.01%
1
BINI
6365
DELISTED
Bollinger Innovations
BINI
0
NNVC icon
6366
NanoViricides
NNVC
$39.5M
-24
Closed -$1K
NSPR icon
6367
InspireMD
NSPR
$31.5M
0
XMAX
6368
XMAX Inc
XMAX
$558M
-2
Closed
OGEN icon
6369
Oragenics
OGEN
$2.21M
0
OPTT icon
6370
Ocean Power Technologies
OPTT
$43.5M
$0 ﹤0.01%
+7
New +$367
PHIO icon
6371
Phio Pharmaceuticals
PHIO
$12M
0
PRPH
6372
DELISTED
ProPhase Labs
PRPH
$0 ﹤0.01%
5
RIOT icon
6373
Riot Platforms
RIOT
$8.36B
-738
Closed -$3K
SCOR icon
6374
Comscore
SCOR
$112M
-10,566
Closed -$6.67M
SGRP
6375
DELISTED
SPAR Group
SGRP
$0 ﹤0.01%
+400
New +$423

Similar funds

Morgan Stanley's Q1 2017 Portfolio in Review

As of Q1 2017, Morgan Stanley held 6,814 positions worth $325B, up 6.5% from $306B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Morgan Stanley's Q1 2017 filing shows 216 new, 2,666 increased, 3,277 reduced and 152 closed positions. Its largest new stake was First Trust Nasdaq Bank ETF: 6,658,594 shares worth $173M. The largest sale was St Jude Medical, an estimated $538M.

By sector, the portfolio is most concentrated in Financials at 9.7% of assets, down from 9.9% a quarter earlier, followed by Technology and Healthcare.

  • Morgan Stanley's largest Q1 2017 buy was First Trust Nasdaq Bank ETF: 6,658,594 shares worth $173M.
  • Morgan Stanley added most to KKR & Co in Q1 2017, an estimated $705M increase.
  • Morgan Stanley's biggest Q1 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $397M.
  • Morgan Stanley fully exited St Jude Medical in Q1 2017, selling an estimated $538M.
  • Morgan Stanley's ten largest holdings make up 12% of its $325B portfolio in Q1 2017.
  • Morgan Stanley opened 216 new positions and closed 152 in Q1 2017.
  • Morgan Stanley's portfolio value rose 6.5% quarter-over-quarter to $325B.

Based on Morgan Stanley's 13F filing for Q1 2017, filed 12 May 2017.